PLIANT THERAPEUTICS, INC. Increase (Decrease) in Income Taxes Receivable
PLIANT THERAPEUTICS, INC. (PLRX) reported Increase (Decrease) in Income Taxes Receivable of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2022-03-01
- PLIANT THERAPEUTICS, INC. increase (decrease) in income taxes receivable for the quarter ending 2021-12-31 was $0.00.
- PLIANT THERAPEUTICS, INC. increase (decrease) in income taxes receivable for the quarter ending 2021-09-30 was $0.00.
- PLIANT THERAPEUTICS, INC. increase (decrease) in income taxes receivable for the quarter ending 2021-06-30 was $0.00.
- PLIANT THERAPEUTICS, INC. increase (decrease) in income taxes receivable for the quarter ending 2021-03-31 was $0.00.
- PLIANT THERAPEUTICS, INC. increase (decrease) in income taxes receivable for fiscal 2021 was $0.00.
- PLIANT THERAPEUTICS, INC. increase (decrease) in income taxes receivable for fiscal 2020 was -$250.00K.
- PLIANT THERAPEUTICS, INC. increase (decrease) in income taxes receivable for fiscal 2019 was -$167.00K.
| Period end | Increase (Decrease) in Income Taxes Receivable 3 month | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 9 month | Increase (Decrease) in Income Taxes Receivable 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | -$178.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | -$178.00K derived: sum of 3 quarters · filed 2022-03-01 | -$250.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$178.00K derived: sum of 2 quarters · filed 2021-11-09 | -$250.00K 10-Q · filed 2021-11-09 | -$437.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$178.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$250.00K 10-Q · filed 2021-08-09 | -$437.00K derived: sum of 3 quarters · filed 2022-03-01 | -$375.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$72.00K 10-Q · filed 2021-05-10 | -$259.00K derived: sum of 2 quarters · filed 2022-03-01 | -$197.00K derived: sum of 3 quarters · filed 2022-03-01 | |
| 2019-12-31 | -$187.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$125.00K derived: sum of 2 quarters · filed 2022-03-01 | -$167.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $20.00K 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | -$42.00K 10-Q · filed 2020-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |